Letter to the Editor: Will Vitamin E Be the Hope of Patients With NASH and Advanced Fibrosis? The Reliability Is Worth Discussing

被引：1
|
作者：
He, Jian [1 ]
Leng, Ai-Min [1 ]
机构：
[1] Cent S Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China
来源：
HEPATOLOGY | 2019年 / 70卷 / 02期
关键词：
FUTURE;
D O I：
10.1002/hep.30603
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：751 / 751
页数：1
相关论文
共 50 条
  • [31] Predictors of Fibrosis Progression and Regression by Histology and Morphometrically Quantified Collagen in Patients with Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
    Younossi, Zobair M.
    Stepanova, Maria
    Sanyal, Arun J.
    Harrison, Stephen A.
    Ratziu, Vlad
    McColgan, Bryan J.
    Myers, Robert P.
    Subramanian, Mani
    McHutchison, John G.
    Afdhal, Nezam H.
    Abdelmalek, Manal F.
    Bosch, Jaime
    Goodman, Zachary D.
    HEPATOLOGY, 2017, 66 : 1171A - 1171A
  • [32] Nerve conduction in vitamin E deficient cystic fibrosis patients
    DeSchepper, J
    HachimiIdrissi, S
    Dab, I
    Schmedding, E
    EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (03) : 251 - 252
  • [33] Vitamin E status and its determinants in patients with cystic fibrosis
    Sapiejka, Ewa
    Krzyzanowska-Jankowska, Patrycja
    Wenska-Chyzy, Ewa
    Szczepanik, Mariusz
    Walkowiak, Dariusz
    Cofta, Szczepan
    Pogorzelski, Andrzej
    Skorupa, Wojciech
    Walkowiak, Jaroslaw
    ADVANCES IN MEDICAL SCIENCES, 2018, 63 (02): : 341 - 346
  • [34] Response to letter to the editor by Kawada on "Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke"
    Parikh, Neal S.
    Gutierrez, Jose
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 408
  • [35] Letter to the Editor: Can plasma FSTL-1 levels serve as a reliable biomarker for advanced fibrosis?
    Emanuele, Enzo
    Minoretti, Piercarlo
    HEPATOLOGY, 2024,
  • [36] Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare
    Cunha, Mateus Trinconi
    Carvalho, Vinicius Jardim
    Loureiro, Rafael Maffei
    Brantis-de-Carvalho, Carlos Eduardo
    Cintra, Murilo Bicudo
    de Castro Junior, Gilberto
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [37] CHANGES IN FIBROSIS, BUT NOT THE NAFLD ACTIVITY SCORE (NAS), ARE ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS
    Sanyal, Arun
    Harrison, Stephen A.
    Ratziu, Vlad
    Abdelmalek, Manal F.
    Diehl, Anna Mae
    Caldwell, Stephen H.
    Shiffman, Mitchell L.
    Aguilar, Raul
    Jia, Catherine
    McColgan, Bryan J.
    Natha, Macky
    Myers, Robert P.
    Subramanian, Mani
    McHutchison, John
    Muir, Andrew J.
    Afdhal, Nezam H.
    Bosch, Jaime
    Goodman, Zachary
    GASTROENTEROLOGY, 2017, 152 (05) : S1055 - S1055
  • [38] SAROGLITAZAR VERSUS VITAMIN E IN PATIENTS WITH BIOPSY PROVEN NASH : A RANDOMISED CONTROLLED TRIAL
    Sharma, Mithun
    Kulkarni, Anand V.
    Sowmya, T. R.
    Jagtap, Nitin
    Rao, Padaki Nagaraja
    Gupta, Rajesh
    Reddy, Duvurr Nageshwar
    HEPATOLOGY, 2022, 76 : S667 - S667
  • [39] Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis
    Vilar-Gomez, Eduardo
    Vuppalanchi, Raj
    Gawrieh, Samer
    Ghabril, Marwan
    Saxena, Romil
    Cummings, Oscar W.
    Chalasani, Naga
    HEPATOLOGY, 2020, 71 (02) : 495 - 509
  • [40] Prediction of fibrosis improvement in patients with advanced fibrosis due to NASH using a machine learning approach: Unravelling the placebo response
    Sanyal, A.
    Nguyen, T.
    Wang, L.
    Xiao, Y.
    Jia, C.
    Xu, R.
    Djedjos, S.
    Subramanian, M.
    Myers, R.
    Ratziu, V.
    Afdhal, N.
    Bosch, J.
    Harrison, S.
    Goodman, Z.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S97 - S97
12345